/ /

Michelle Dalton, ELS
Entry wound complications: Unexpected entry site hemorrhage proved difficult to manage
Using valved cannulas during phacovitrectomy is highly recommended when an unexpected site hemorrhage becomes difficult to manage.
Sustained-release bimatoprost implant addresses challenges of adherence
Phase I/II interim data for a bimatoprost sustained-release implant show the device has favorable safety and efficacy and may address the problem of patient nonadherence.
Rocket 2 results may tip the scale
Aerie recently reported the results of its second phase III registration trial in the United States named Rocket 2, where the primary efficacy endpoint was to demonstrate non-inferiority of IOP lowering for Rhopressa compared with timolol.
Long-term implant showing potential in glaucoma therapy
An extended-release therapy that encapsulates travoprost in an intracameral implant showed a statistically significant and clinically meaningful reduction in IOP with results comparable to topical once-daily travoprost ophthalmic solution, said Tom R. Walters, MD, Texan Eye, Austin.
Drug therapies improving refractive outcomes
Lines continue to blur as to what constitutes refractive surgery, and likely will continue to blur well into the future. Multiple compounds—phenylephrine and ketorolac 1%/0.3%, (Omidria, Omeros) and the “Dropless” line (Tri-Moxi/Tri-moxi-Vanc, Imprimis Pharmaceuticals)—are designed for use in cataract surgery, but their goal is to improve refractive outcomes. 2015 was the year they started to get some serious attention.
ROCK inhibitors show promise in glaucoma treatment
A novel class of drugs ‒ rho-kinase, or ROCK inhibitors ‒ appears to lower IOP by relaxing the trabecular meshwork.
ASCs are a winning proposition for cataract patients, surgeons
Working in an ambulatory surgery center can be a good choice for ophthalmologists, particularly cataract surgeons, because they let them use their time efficiently while delivering excellent care without the hassles of working in a larger hospital setting where ophthalmology may not be a priority.
Nitric oxide: A potential target for glaucoma treatment
Evidence suggests that nitric oxide can modify both mechanical and vascular events in primary open-angle glaucoma pathogenesis.
Ultra-widefield imaging: Coming into its own
Ultra-widefield (UWF) imaging provides clinicians a much broader view of the retinal periphery. The Optos California uses multiple UWF imaging modalities, including color, autofluorescence, fluorescein angiography (FA), and indocyanine green (ICG) angiography in a 200° picture.
Technologic advances integrate OCT into real-time surgeries
Researchers are conducting a prospective, multisurgeon, single-center study to evaluate multiple microscope integrated-prototypes with real-time surgeon feedback.


View Results